Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey

• Published in: The journal of clinical psychiatry Vol. 74; no. 1; p. e87
• Main Authors: Lensing, Michael B, Zeiner, Pål, Sandvik, Leiv, Opjordsmoen, Stein
• Format: Journal Article
• Language: English
• Published: United States 01.01.2013
• Subjects: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity - diagnosis; Attention Deficit Disorder with Hyperactivity - drug therapy; Attention Deficit Disorder with Hyperactivity - psychology; Central Nervous System Stimulants - adverse effects; Central Nervous System Stimulants - therapeutic use; Delayed-Action Preparations; Dextroamphetamine - adverse effects; Dextroamphetamine - therapeutic use; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Methylphenidate - adverse effects; Methylphenidate - therapeutic use; Norway; Prognosis; Propylamines - adverse effects; Propylamines - therapeutic use; Surveys and Questionnaires; Treatment Outcome; Norway
• ISSN: 1555-2101
• DOI: 10.4088/JCP.12m07714

In adults with attention-deficit/hyperactivity disorder (ADHD), pharmacotherapy is a recommended treatment option. However, research on long-term outcome with such treatment has been scarce. A questionnaire survey was completed by adults with ADHD, diagnosed according to ICD-10/DSM-IV criteria and a...